EMN
Eastman Chemical Company
$74.31
+$0.19(+0.25%)
75
Overall
100
Value
80
Tech
47
Quality
Market Cap
$6.89B
Volume
335.82K
52W Range
$56.11 - $83.47
Target Price
$83.21
Order:
Income Statement
| Metric | Trend | Chart | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec | 2025 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $9.0B | $9.5B | $10.2B | $9.3B | $8.5B | $10.5B | $10.6B | $9.2B | $9.4B | $8.8B | ||
| Total Revenue | $9.0B | $9.5B | $10.2B | $9.3B | $8.5B | $10.5B | $10.6B | $9.2B | $9.4B | $8.8B | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | $6.7B | $7.2B | $7.7B | $7.0B | $6.5B | $8.0B | $8.4B | $7.1B | $7.1B | $7.3B | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $2.4B | $2.4B | $2.5B | $2.2B | $2.0B | $2.5B | $2.1B | $2.1B | $2.3B | $1.8B | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $922.0M | $1.1B | $1.3B | $985.0M | $999.0M | $637.0M | $889.0M | $1.0B | $1.3B | $888.0M | ||
| Research & Development | $219.0M | $530.0M | $235.0M | $234.0M | $226.0M | $254.0M | $264.0M | $239.0M | $250.0M | $255.0M | ||
| Research Expense | $219.0M | $227.0M | $235.0M | $234.0M | $226.0M | $254.0M | $264.0M | $239.0M | $250.0M | $255.0M | ||
| Selling, General & Administrative | $703.0M | $729.0M | $1.0B | $691.0M | $654.0M | $795.0M | $726.0M | $727.0M | $736.0M | $658.0M | ||
| Selling & Marketing Expenses | $703.0M | $729.0M | $1.0B | -- | -- | $380.0M | -- | $377.0M | -- | -- | ||
| General & Administrative Expenses | $-90.0M | $-94.0M | $-65.0M | $691.0M | $654.0M | $795.0M | $726.0M | $727.0M | $736.0M | $658.0M | ||
| Salaries & Wages | $-36.0M | $-135.0M | $-21.0M | $60.0M | $119.0M | $-412.0M | $-101.0M | $41.0M | $310.0M | $-25.0M | ||
| Depreciation & Amortization | $-580.0M | $-587.0M | $-604.0M | $611.0M | $574.0M | $538.0M | $477.0M | $498.0M | -- | -- | ||
| Depreciation & Amortization | $-580.0M | $-587.0M | $-604.0M | $611.0M | $363.0M | $538.0M | -- | -- | -- | -- | ||
| Amortization | $-166.0M | $-164.0M | $-164.0M | $4.4B | $4.5B | $-398.0M | $3.7B | $-67.0M | -- | -- | ||
| Other Operating Expenses | $97.0M | $-21.0M | $99.0M | $143.0M | $240.0M | $-267.0M | -- | -- | -- | -- | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $1.1B | $1.2B | $1.2B | $1.2B | $976.0M | $1.9B | $1.2B | $1.1B | $994.0M | $574.0M | ||
| EBITDA | $1.3B | $1.6B | $1.7B | $1.5B | $1.3B | $1.8B | $1.6B | $1.8B | $1.8B | $1.3B | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | -- | -- | -- | $218.0M | $210.0M | $198.0M | $188.0M | $215.0M | $200.0M | $208.0M | ||
| Intinc | $6.0M | $-4.0M | $53.0M | -- | -- | -- | -- | -- | $16.0M | -- | ||
| Net Non-Operating Interest Income/Expense | $6.0M | $-4.0M | $53.0M | $-218.0M | $-210.0M | $-198.0M | $-182.0M | $-215.0M | $-200.0M | $-208.0M | ||
| Gain on Sale of Securities | $15.0M | $12.0M | $17.0M | $10.0M | $15.0M | $16.0M | -- | -- | -- | -- | ||
| Other Income/Expense | $85.0M | $-15.0M | $7.0M | $350.0M | $9.0M | $536.0M | $-89.0M | $-285.0M | $47.0M | $84.0M | ||
| Other Special Charges | $-85.0M | -- | $-7.0M | $-3.0M | $-9.0M | $16.0M | $6.0M | $-38.0M | $-47.0M | $-84.0M | ||
| SPECIAL ITEMS | ||||||||||||
| Restructring And Mn A Income | $45.0M | $8.0M | $45.0M | $126.0M | $227.0M | $47.0M | $52.0M | $37.0M | $51.0M | $96.0M | ||
| Special Income Charges | $-45.0M | $-8.0M | $-29.0M | $-126.0M | $-227.0M | $-47.0M | $-52.0M | $-37.0M | $-51.0M | $-96.0M | ||
| Impairment of Capital Assets | $-12.0M | $-1.0M | $-39.0M | $72.0M | $146.0M | $16.0M | -- | -- | -- | -- | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $769.0M | $1.0B | $1.1B | $885.0M | $740.0M | $1.3B | $1.2B | $1.3B | $1.3B | $776.0M | ||
| Pre-Tax Income | $1.0B | $1.3B | $1.3B | $902.0M | $530.0M | $1.1B | $977.0M | $1.1B | $1.1B | $568.0M | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $190.0M | $-99.0M | $226.0M | $140.0M | $41.0M | $215.0M | $181.0M | $191.0M | $170.0M | $93.0M | ||
| NET INCOME | ||||||||||||
| Net Income | $859.0M | $1.4B | $1.1B | $759.0M | $478.0M | $857.0M | $793.0M | $894.0M | $905.0M | $474.0M | ||
| Net Income (Continuing Operations) | $859.0M | $1.4B | $1.1B | $759.0M | $478.0M | $857.0M | $796.0M | $896.0M | $908.0M | $475.0M | ||
| Net Income (Discontinued Operations) | $859.0M | $1.4B | $1.1B | $759.0M | $478.0M | $857.0M | $793.0M | $894.0M | $905.0M | $474.0M | ||
| Net Income (Common Stockholders) | $575.0M | $1.1B | $771.0M | $412.0M | $478.0M | $857.0M | $793.0M | $894.0M | $905.0M | $474.0M | ||
| TOTALS | ||||||||||||
| Total Expenses | $7.6B | $8.3B | $8.9B | $8.0B | $7.5B | $8.6B | $9.3B | $8.2B | $8.4B | $8.2B | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $147.3M | $144.8M | $141.2M | $137.4M | $135.5M | $134.9M | $123.5M | $118.6M | $116.8M | $114.5M | ||
| Average Shares Outstanding (Diluted) | $148.4M | $146.1M | $142.9M | $138.5M | $136.5M | $137.1M | $124.9M | $342.5M | $118.0M | $115.6M | ||
| Shares Outstanding | $146.5M | $143.0M | $139.8M | $136.0M | $135.9M | $129.0M | $114.3M | $117.3M | $115.2M | $114.1M | ||
| Basic EPS | $5.8 | $9.56 | $7.65 | $5.52 | $3.53 | $6.35 | $6.42 | $7.54 | $7.75 | $4.14 | ||
| Basic EPS (Continuing Operations) | $5.8 | $9.56 | -- | $5.52 | $3.53 | $6.35 | $6.42 | $7.54 | $7.75 | $4.14 | ||
| Diluted EPS | $5.75 | $9.47 | $7.56 | $5.48 | $3.5 | $6.25 | $6.35 | $7.49 | $7.67 | $4.1 | ||
| Diluted EPS (Continuing Operations) | $5.75 | $9.47 | -- | $5.48 | $3.5 | $6.25 | $6.35 | $7.49 | $7.67 | $4.1 | ||
| Dividend Per Share | $1.89 | $2.09 | $2.3 | $2.52 | $2.67 | $2.83 | $3.07 | $3.18 | $3.26 | $3.33 | ||
| OTHER METRICS | ||||||||||||
| Acquired In Process Rn D | -- | -- | $16.0M | -- | -- | -- | -- | -- | -- | -- | ||
| Commission Expenses | -- | -- | $325.0M | -- | -- | $380.0M | -- | -- | -- | -- | ||
| Depletion | -- | -- | -- | -- | $363.0M | -- | -- | -- | -- | -- | ||
| Development Expense | -- | $303.0M | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings from equity interest | $17.0M | $3.0M | $16.0M | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings From Equity Interest Net Of Tax | $17.0M | $3.0M | $16.0M | -- | -- | -- | -- | -- | -- | -- | ||
| Excise Taxes | -- | -- | $325.0M | -- | -- | -- | -- | -- | -- | -- | ||
| Gain On Sale Of Business | -- | -- | -- | -- | -- | $-552.0M | $-43.0M | $323.0M | -- | -- | ||
| Gain On Sale Of P P E | $2.0M | -- | -- | $-20.0M | -- | -- | -- | -- | -- | -- | ||
| Insurance And Claims | -- | -- | $-65.0M | -- | -- | -- | -- | -- | -- | -- | ||
| Interest Expense Operating | $-280.0M | $-263.0M | $-239.0M | $-235.0M | $-191.0M | $-170.0M | $377.0M | -- | -- | -- | ||
| Loss And Loss Adjustment Expected Incurred | -- | $303.0M | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Minority Interests | $-5.0M | $-4.0M | $-4.0M | $-3.0M | $-11.0M | $-10.0M | $-3.0M | $-2.0M | $-3.0M | $-1.0M | ||
| Net Operating Interest Income Expense | $-255.0M | $-241.0M | $-235.0M | -- | -- | -- | -- | -- | -- | -- | ||
| Other Gand A | $-90.0M | $-94.0M | $-65.0M | $691.0M | $654.0M | $795.0M | $726.0M | $727.0M | $736.0M | $658.0M | ||
| Other Impairment Of Capital Assets | -- | -- | -- | $45.0M | $125.0M | $-1.0M | -- | -- | $5.0M | $33.0M | ||
| Other Taxes | -- | -- | -- | $347.0M | -- | -- | -- | -- | -- | -- | ||
| Other Write Down | -- | -- | -- | -- | -- | -- | -- | -- | $382.0M | -- | ||
| Rent And Landing Fees | $-90.0M | $-94.0M | $-103.0M | -- | -- | -- | -- | -- | -- | -- | ||
| Selling Expense | $703.0M | $729.0M | $721.0M | -- | -- | -- | -- | -- | -- | -- | ||
| Write Down | -- | $-1.0M | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Restruct | $45.0M | $8.0M | $45.0M | $126.0M | $227.0M | $47.0M | $52.0M | $37.0M | $51.0M | $96.0M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | EMN | $74.31 | +0.2% | 335.82K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Eastman Chemical Company Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW